Disc Medicine (IRON) Shares Outstanding (Weighted Average) (2020 - 2026)

Disc Medicine (IRON) has 7 years of Shares Outstanding (Weighted Average) data on file, last reported at $38.5 million in Q1 2026.

• Quarterly Shares Outstanding (Weighted Average) rose 15.5% year-over-year to $38.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $38.5 million (up 15.5% YoY) and the FY2025 annual result came in at $35.3 million, up 27.85% from the prior year.
• Shares Outstanding (Weighted Average) improved to $38.5 million in Q1 2026 per IRON's latest filing, from $35.3 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $43.3 million in Q3 2022 and bottomed at $204081.0 in Q2 2023.
• The 5-year median for Shares Outstanding (Weighted Average) is $27.6 million (2024), against an average of $25.6 million.
• The widest annual swing landed in 2023, when Shares Outstanding (Weighted Average) sank 99.53%; it then soared 12262.47% in 2024.
• Tracing IRON's Shares Outstanding (Weighted Average) over 5 years: stood at $1.0 million in 2022, then surged by 2046.81% to $22.3 million in 2023, then advanced by 23.71% to $27.6 million in 2024, then grew by 27.85% to $35.3 million in 2025, then gained by 9.05% to $38.5 million in 2026.
• Per Business Quant, the three latest IRON Shares Outstanding (Weighted Average) figures stand at $38.5 million (Q1 2026), $35.3 million (Q4 2025), and $34.5 million (Q3 2025).

Peer Comparison